Eledon Pharmaceuticals, Inc.

ELDN Healthcare Biotechnology

In the quarter to June 2026, EPS fell 107.7% and free cash flow fell 28.0%, each against the same quarter a year earlier.

2.27 0.02 +0.89%
Market cap
$190.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
93.09 113.57 135.69 96.30
Total non-current assets
33.00 33.09 33.32 33.56
Total Assets
126.09 146.67 169.01 129.86
Total current liabilities
11.79 13.46 18.34 14.30
Total non-current liabilities
42.27 32.75 13.89 24.51
Total liabilities
54.06 46.21 32.23 38.80
Common Equity (Total)
33.01 44.76 81.09 35.36
Shareholders Equity (Total)
72.03 100.46 136.78 91.05

Show all line items

In millions of $ except per-share values · columns are period end dates